VS
V SrivatsaFund Manager Since 3 Mar 2017
EquitySector - Healthcare
UTI Healthcare Fund-Growth Option- Direct
3Y Annualised
27.05%
0.08% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
1.33%
0.08% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
2 years 11 months
NIFTY 50
8 years 7 months
FD
9 years 7 months
Fund info
Fund size
₹1143.58 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
Period of Holding < 30 - 1%, Period of Holding = 30 days - Nil
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Groww BSE Hospitals ETF
2.94%
2nd
DSP Healthcare Fund Direct Reinvestment of Income Distribution cum capital withdrawal option
2.91%
3rd
DSP Healthcare Fund Direct Payout of Income Distribution cum capital withdrawal option
2.91%
4th
DSP Healthcare Fund Direct Growth
2.91%
5th
Kotak Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
2.81%
27th
UTI Healthcare Fund-Growth Option- Direct
1.33%
Fund Managers
KG
Kamal GadaFund Manager Since 2 May 2022
About UTI Healthcare Fund-Growth Option- Direct
UTI Healthcare Fund-Growth Option- Direct is a Equity mutual fund scheme from UTI Asset Management Co Ltd. This fund has been in existence for 13 years, having been launched on 2013-01-01. UTI Healthcare Fund-Growth Option- Direct has ₹1143.58 Cr worth of assets under management (AUM) as of Tue Jun 09 2026. The latest Net Asset Value (NAV) of UTI Healthcare Fund-Growth Option- Direct as of Mon Jun 08 2026 is ₹350.0769. The fund has an expense ratio of 1.36%, which is medium comparable to most other Equity funds.
UTI Healthcare Fund-Growth Option- Direct returns for the last 1 year are 11.13%. Since launch, it has delivered 16.00% average annual returns.
The UTI Healthcare Fund-Growth Option- Direct has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of UTI Healthcare Fund-Growth Option- Direct.
- Sun Pharmaceuticals Industries Ltd: 9.49%
- Ajanta Pharma Ltd: 5.84%
- Lupin Ltd: 4.23%
- Apollo Hospitals Enterprise Ltd: 3.54%
- Divi's Laboratories Ltd: 3.45%
AMC Information
| Name | UTI Asset Management Co Ltd |
|---|---|
| Founding Date | 2013-01-01 |
| pms_care@uti.co.in | |
| Phone | +91-22-6678 6666 |
| Website | https://www.utiwms.com |
| Address | PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051 |
Tax Implications of UTI Healthcare Fund-Growth Option- Direct
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from UTI Asset Management Co Ltd
UTI Conservative Hybrid Fund Regluar Plan Growth
AllocationConservative Allocation
3Y CAGR
7.63%
expense ratio
1.96%
fund size
₹1652.19 Cr
UTI MNC Fund Regular Plan Growth
EquityEquity - Other
3Y CAGR
9.45%
expense ratio
2.98%
fund size
₹2662.13 Cr
UTI Large cap Fund Regular Plan Growth
EquityLarge-Cap
3Y CAGR
7.92%
expense ratio
1.94%
fund size
₹12052.60 Cr
UTI Mid Cap Fund Regular Plan Growth
EquityMid-Cap
3Y CAGR
13.40%
expense ratio
2.09%
fund size
₹11679.71 Cr
UTI Value fund Fund-Direct Growth Option
EquityValue
3Y CAGR
14.56%
expense ratio
1.52%
fund size
₹9433.00 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
